Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
about
Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three StudiesAn analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data.Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathologyAtypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Genetic basis of lipoprotein disorders.Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipaseMetabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia)High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia)Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemiaSimultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemiaMonoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein BApolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrationsStructural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyThe isolation of cDNA clones for human apolipoprotein E and the detection of apoE RNA in hepatic and extra-hepatic tissues.Vitamin K nutrition, metabolism, and requirements: current concepts and future research.Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotypeThe role of calcium in lipoprotein release by the low-density lipoprotein receptor.Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia.ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?Identification of roles for H264, H306, H439, and H635 in acid-dependent lipoprotein release by the LDL receptor.The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.Hepatic chylomicron remnant (apolipoprotein E) receptors. Their physiologic and clinical importance.Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.Severe xanthomatosis associated with familial apolipoprotein E deficiency.Synthesis of apolipoprotein E by peripheral tissues. Potential functions in reverse cholesterol transport and cellular cholesterol metabolism.Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3.
P2860
Q28552731-4018434A-A34A-4434-A19B-77FD86C10F19Q31160120-A64C4DF2-65CF-4F33-9330-46FDCCB80F72Q33811028-E4686810-33CC-43F7-B8C6-E60A3E16B0F9Q33821952-CC57E49C-EEA6-43AD-A093-784D37AEA385Q33822165-1944530F-C6FB-40A5-8DE7-ACBCBBF491FFQ33847743-1D85E30B-3482-4B7F-96E6-3D0FCD8D791CQ34245790-9A99565A-5636-439D-81E2-0A26F259F63FQ34305393-4D39D471-7454-422E-87F7-2995E31AB5DCQ34533065-159F5E57-8536-48E5-A635-1A75B589FCEDQ34538275-CC26582A-9278-424A-9670-DEB504C1FF76Q34560246-D2CF7486-566E-4138-A2E5-0252A2C0CC03Q34581286-C96257B4-B9FD-4331-8608-E3632926F721Q34606014-233D4898-4BBE-4514-AFE3-EAF448EE7CA2Q34616680-A77CE2CE-4324-4370-A13C-CFC185C30263Q35197088-E8F74CC4-F16E-4F10-A766-93AC1D120FADQ35200206-103D31E5-B2D7-4BAD-AE2B-E4FF9CAD892BQ35205251-21C0DC89-F63F-4A88-AC02-7640EC0FBD83Q35205937-CC0A262C-E50E-456E-8889-267340945D43Q35246448-74F0C037-B3AB-4EF9-8F7F-4A42856A5DC7Q35580326-B927C523-7CED-4849-93FF-FFB9E7800A08Q35591182-4AFFDF73-E3D5-4DA3-818D-69CC12F9FF77Q35763180-F073545A-3095-46B9-BA24-4E4E6DB0D105Q35889081-5CA9C0E4-42B7-4EA2-8FC1-30FB4FF56FB7Q36306690-FA379503-7A45-4991-BF31-57577779944BQ36558367-5BF785F6-6F57-45EB-8044-9D7E01AA4FF7Q36592147-E755ADA8-DF88-41F9-9704-33A8821CFEB2Q36828726-DBBCA68E-A662-4479-A82C-3F32A28DECBCQ36991404-EE971D22-B011-48EA-94C1-2537A45E49DEQ37357958-5FFEFE7F-BC90-4FD2-96A6-D933322E4D9FQ37566831-3702B1C5-AE00-4F24-9E4D-8A9BEBB41F90Q37614130-99A5A92E-B58C-411B-924C-4581DFB7FC79Q38190156-787F1D2E-44A1-4CF3-9EB2-21FB453BFB0DQ38728542-EF26C609-1395-4314-99BE-88CA207487D7Q38959290-9BE334DA-3A8A-4173-9FD0-5D22EEFF0CF8Q39136819-C53CBE7B-6C8F-4AB8-892C-D150FC216704Q39257249-BD202B07-A4F5-4A6D-8668-48F935C19233Q39498138-9D98E672-B44C-477C-BFB9-A9DB14B62693Q39558258-886FC13D-8ADF-48B3-919B-8B1DD1BAB761Q39836518-537E6DC8-65EF-43DE-8E6C-02999BEBCAE0Q41198061-5D52849D-F401-464F-9008-D13DF49639B8
P2860
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1981
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@en
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@nl
type
label
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@en
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@nl
prefLabel
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@en
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@nl
P2093
P2860
P356
P1476
Familial dysbetalipoproteinemi ...... al of rats, rabbits, and cows.
@en
P2093
G Utermann
J L Goldstein
P T Kovanen
R W Mahley
T L Innerarity
W J Schneider
P2860
P304
P356
10.1172/JCI110330
P407
P577
1981-10-01T00:00:00Z